loadpatents
Patent applications and USPTO patent grants for O'NEILL; David John.The latest application filed is for "rapamycin analogs and uses thereof".
Patent | Date |
---|---|
Rapamycin Analogs And Uses Thereof App 20220267352 - O'NEILL; David John ;   et al. | 2022-08-25 |
Modulators of Sestrin-GATOR2 interaction and uses thereof Grant 11,325,924 - Fetalvero , et al. May 10, 2 | 2022-05-10 |
Rapamycin Analogs And Uses Thereof App 20210220339 - SAIAH; Eddine ;   et al. | 2021-07-22 |
Rapamycin Analogs And Uses Thereof App 20210186935 - O'NEILL; David John ;   et al. | 2021-06-24 |
Rapamycin analogs and uses thereof Grant 10,980,784 - Saiah , et al. April 20, 2 | 2021-04-20 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20210047347 - FETALVERO; Kristina Michelle ;   et al. | 2021-02-18 |
Phenyl amino piperidine mTORC inhibitors and uses thereof Grant 10,844,013 - O'Neill , et al. November 24, 2 | 2020-11-24 |
Modulators of Sestrin-GATOR2 interaction and uses thereof Grant 10,752,644 - Fetalvero , et al. A | 2020-08-25 |
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF App 20200207716 - O'Neill; David John ;   et al. | 2020-07-02 |
Rapamycin analogs and uses thereof Grant 10,683,308 - Saiah , et al. | 2020-06-16 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20200079800 - Fetalvero; Kristina Michelle ;   et al. | 2020-03-12 |
Rapamycin Analogs And Uses Thereof App 20190388401 - Saiah; Eddine ;   et al. | 2019-12-26 |
PYRROLE mTORC INHIBITORS AND USES THEREOF App 20190389843 - O'Neill; David John ;   et al. | 2019-12-26 |
Phenyl amino piperidine mTORC inhibitors and uses thereof Grant 10,414,727 - O'Neill , et al. Sept | 2019-09-17 |
Modulators of sestrin-GATOR2 interaction and uses thereof Grant 10,414,782 - Fetalvero , et al. Sept | 2019-09-17 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20190048029 - Fetalvero; Kristina Michelle ;   et al. | 2019-02-14 |
Rapamycin Analogs And Uses Thereof App 20190031683 - Saiah; Eddine ;   et al. | 2019-01-31 |
Modulators of sestrin-GATOR2 interaction and uses thereof Grant 10,100,066 - Fetalvero , et al. October 16, 2 | 2018-10-16 |
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF App 20180127370 - O'Neill; David John ;   et al. | 2018-05-10 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20170114080 - Fetalvero; Kristina Michelle ;   et al. | 2017-04-27 |
Polar Quinazolines App 20100184786 - Travins; Jeremy Mark ;   et al. | 2010-07-22 |
Quinoxaline-based Lxr Modulators App 20100120778 - Hu; Baihua ;   et al. | 2010-05-13 |
Aryl Sulfamide Derivatives And Methods Of Their Use App 20100029641 - McComas; Casey Cameron ;   et al. | 2010-02-04 |
Aryl sulfamide derivatives and methods of their use Grant 7,601,722 - McComas , et al. October 13, 2 | 2009-10-13 |
Hydroxy-substituted Aryl Sulfamide Derivatives And Methods Of Their Use App 20080194654 - McComas; Casey Cameron ;   et al. | 2008-08-14 |
Aryl Sulfamide Derivatives And Methods Of Their Use App 20080167303 - McComas; Casey Cameron ;   et al. | 2008-07-10 |
Aminoalkyl Substituted Aryl Sulfamide Derivatives And Methods Of Their Use App 20080161366 - McComas; Casey Cameron ;   et al. | 2008-07-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.